Stage IA NSCLC VATS Outcomes with Intrapleural Hemocoagulase, 442 Patients

Yingding Ruan's dataset from 2026 analyzes the effects of intrapleural Hemocoagulase Bothrops atrox (HBA) on coagulation and recovery after video-assisted thoracoscopic surgery (VATS) for stage IA non-small cell lung cancer. It contains a retrospective analysis of 442 patients, with 92 in the HBA group and 350 in the non-HBA group. The data includes primary outcomes on postoperative coagulation and secondary outcomes on length of stay and complications.

Use Cases

• Analyze the association between intrapleural HBA and coagulation parameters like prothrombin time and fibrinogen levels.
• Model the relationship between HBA use and postoperative complication rates.
• Predict postoperative hospital length of stay based on treatment group and patient characteristics.
• Conduct propensity score matching or inverse probability weighting analyses on surgical cohort data.

Strengths

• Dataset includes results from 442 stage IA NSCLC patients, providing a substantial cohort for analysis.
• Analysis uses inverse probability of treatment weighting (IPTW) to balance baseline characteristics, suggesting methodological rigor.
• Specific numerical results are provided, such as a 6.5% vs. 12.0% complication rate and a mean prothrombin time difference of 0.52 seconds.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is from a single retrospective study, which may reflect inherent selection biases.

Provenance

Source

Yingding Ruan via figshare

Collection Method

Retrospective analysis of patient records.

Time Range

The temporal coverage of the underlying patient data is not specified.

Freshness

Last updated 2026-04-10 05:29:36; freshness should be verified.

Geography

The geographic coverage of the patient population is not specified.